1160 studies found for:    "Alzheimer disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Alzheimer disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Alzheimer's Disease Genetics Study
Conditions: Alzheimer Disease;   Late Onset Alzheimer Disease;   Dementia
Intervention:
2 Recruiting Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
Conditions: Early Onset Alzheimer Disease;   Alzheimer Disease;   Obstructive Sleep Apnea Syndromes
Interventions: Device: CPAP Treatment;   Device: No treatment
3 Recruiting Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
Conditions: Alzheimers Disease;   Dementia;   Alzheimers Disease, Familial
Interventions: Drug: Gantenerumab;   Drug: Solanezumab;   Drug: Matching Placebo (Gantenerumab);   Drug: Matching Placebo (Solanezumab)
4 Completed Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild to Moderate Alzheimers Disease
Interventions: Drug: GSK239512;   Drug: Placebo
5 Completed A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
Conditions: Mild-to-moderate Alzheimer's Disease;   Alzheimer's Disease
Interventions: Drug: SB-742457 15mg;   Drug: SB-742457 35mg;   Drug: Placebo;   Drug: donepezil 5-10mg
6 Recruiting Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease;   Prodromal Alzheimer's Disease
Interventions: Drug: MK-8931;   Drug: Placebo
7 Completed GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
Condition: Alzheimer Disease
Intervention: Drug: DMXB-A
8 Recruiting MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
Condition: Alzheimer Disease
Interventions: Drug: RO4602522;   Drug: RO4601522;   Drug: placebo;   Drug: donepezil;   Drug: rivastigmine;   Drug: galantamine;   Drug: memantine
9 Completed Assessment of Sleep Disturbance in Alzheimer Disease
Condition: Alzheimer Disease
Intervention: Other: Analysis of sleep disturbance
10 Completed Alzheimer's Disease Prevention Trial
Conditions: Alzheimer Disease;   Memory Disorders
Interventions: Drug: Estrogen;   Drug: Estrogen and Progesterone
11 Unknown  Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids
Conditions: Alzheimer Disease;   Presbycusis
Intervention: Device: Hearing aids used : PHONAK Savia and Valeo
12 Completed Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
Conditions: Alzheimer's Disease;   Posterior Cortical Atrophy;   Logopenic Progressive Aphasia
Intervention:
13 Active, not recruiting Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls
Conditions: Parkinson Disease;   Alzheimer Disease
Intervention: Drug: [18F] CFPyPB
14 Recruiting A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg /kg;   Drug: BAN2401 5 mg /kg;   Drug: BAN2401 10 mg /kg;   Drug: Placebo
15 Completed Development of NIC5-15 in the Treatment of Alzheimer's Disease
Conditions: Alzheimer Disease;   Dementia
Interventions: Drug: NIC5-15;   Drug: Placebo
16 Completed A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
Condition: Alzheimer's Disease
Interventions: Other: MRI;   Other: FDG-PET
17 Unknown  Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease
Conditions: Cognitive Impairment;   Alzheimer Disease
Interventions: Drug: Lithium Carbonate;   Drug: Placebo
18 Recruiting A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: JNJ-54861911 10 mg;   Drug: JNJ-54861911 50 mg;   Drug: Placebo
19 Unknown  Far Infrared Treatment for Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
20 Completed Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Raloxifene

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years